Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells.

Kumbhari, Adarsh

Optimisation of anti-cancer peptide vaccines to preferentially elicit high-avidity T cells. [electronic resource] - Journal of theoretical biology 02 2020 - 110067 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

1095-8541

10.1016/j.jtbi.2019.110067 doi


Cancer Vaccines
Humans
Neoplasms--therapy
Peptides
T-Lymphocytes, Cytotoxic
Vaccines, Subunit